Expression of interleukin 2 receptors on activated human B cells - Wikidata - awgldk - TriplyDB

Expression of interleukin 2 receptors on activated human B cells

Expression of interleukin 2 receptors on activated human B cells

http://www.wikidata.org/entity/Q36349561

about

Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytes Identification of a cDNA for a human high-molecular-weight B-cell growth factor Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences Guidelines for information about therapy experiments: a proposal on best practice for recording experimental data on cancer therapy Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene.Blockade of the interleukin-2 receptor by anti-Tac antibody inhibits the generation of antigen-nonspecific suppressor T cells in vitro.Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2 Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association.A simple guide to the terminology and application of leucocyte monoclonal antibodies.Methotrexate and a spleen tyrosine kinase inhibitor cooperate to inhibit responses to peripheral blood B cells in rheumatoid arthritis.The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor.Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.Interleukin 6 gene expression in normal and neoplastic B cells.The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation CpG methylation changes within the IL2RA promoter in type 1 diabetes of childhood onset.On the role of sIL-2R measurements in rheumatoid arthritis and cancers.Studies using the anti-idiotypic monoclonal antibody 105AD7 in patients with primary and advanced colorectal cancer.Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7 Cytokines in inflammatory bowel disease.B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.Immunophenotyping of non-Hodgkin's lymphoma. Correlation with relapse-free survival.Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases Development of plasmacytoid cells with Russell bodies in autoimmune "viable motheaten" mice.A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.Phase I study of intra-arterial interleukin-2 in squamous cell carcinoma of the head and neck.Bladder Cancer Immunotherapy: BCG and Beyond.Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferation Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness Terminal maturation of resting B cells by proliferation-independent B cells differentiation factors.The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells.Regulation by recombinant interleukin-2 of protective immunity against recurrent herpes simplex virus type 2 genital infection in guinea pigs.Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria.Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity IL-21 signalling via STAT3 primes human naive B cells to respond to IL-2 to enhance their differentiation into plasmablasts.The immunotherapy of human cancer with interleukin 2: present status and future directions.

P2860

Q24298467-CE4AC92D-3A85-4E31-8E3E-CC7A8F0A6B72 Q24309517-A0CAF320-61F1-41C6-BFDF-F76804967D59 Q24558671-40FEC257-7CC0-4257-8958-25CA80A7903F Q28731819-D8317EBD-E5CC-4B26-BB57-0F097FDDD35F Q33578516-C38D598E-2B41-4A98-957E-02C1AA3D4E1A Q33611936-AA10C9CC-9780-4FAE-83C3-C4A4B6F56E74 Q33645011-C99B27CF-DDFB-43A5-BA72-333977A3E3F6 Q33861934-74C1B821-FE9D-4C98-A5A8-26E56DED6CE2 Q34115915-5D6E5791-F318-4FB8-95C2-A510494E3564 Q34172760-A2F4282E-D4E0-440F-B555-641213F54EFA Q34292553-3E4D8BA0-9370-4E0A-9D24-91F5418461D7 Q34334821-39C80008-B7FF-456D-B36E-536E7458B44D Q34392919-1EAAFE8A-FF44-4A9B-85A0-480B17E1E820 Q34416149-AD285020-D990-4BA0-BA31-14E8253353E8 Q34528269-FFF44F5F-A508-4E27-A82E-AE9886430606 Q34572044-89D4BE55-BE69-4A6E-BA27-B0F1BC85CA54 Q34659968-BC73A758-E973-4851-B26F-EBA8972822A1 Q34846677-61B94292-8B17-4F61-A266-9ED61415ABA1 Q34894394-565479A0-4C9C-492C-B771-6F221EB7BC1F Q34979517-04C8F8F2-6A10-4FC5-90A3-DAE3E5921B33 Q35357417-0C7F4483-C57F-4D04-A917-1E8A116FA5FE Q35556914-132C6E6F-D8E8-4F41-88B3-40E40AE7C19C Q35576711-4C5E9990-D084-445C-9CF1-9611410A8AE9 Q35698637-55323F73-7EEF-4EEE-8842-3A37AEE4E5BA Q35818386-DD535023-45DD-43D6-A292-0EC11072C96D Q35855947-83F60F1B-4F60-41E7-A52D-1CE09E29F6BB Q35855981-344D75F1-878E-472E-8E69-1F1F4A333BBF Q35976681-C5388181-28F9-428E-BE57-1B6B305DA0D0 Q35994118-779FEC87-3D46-4D88-8501-65A28D7B3DCF Q36072179-87ADA1C8-24F2-4ECF-B549-EC19E4B2BA36 Q36292676-434842CA-A587-4B2D-BC25-4A414B96023F Q36350305-1505ABF1-B6A7-4F58-8AD6-37C541285F0D Q36350373-E4A77CB9-EFD0-47ED-A632-D5A51A3ABF61 Q36352314-2243AA75-A111-4896-8350-C66387201A9D Q36354704-557A3B3F-630D-410B-A31B-44B768A3720B Q36889622-DDD1C705-C96F-4E1F-B5B8-673CE7E5B798 Q37017209-0983B2CE-3990-4799-B1C9-4558F73EDBB7 Q37066127-45CBBE37-C7D8-49D0-B992-CAE6C799D6C4 Q37370670-D812751F-FED3-4BD0-9DCF-9B5E84781FE1 Q37427683-6061C032-96EA-4326-957F-CEE674214B07

P2860

Expression of interleukin 2 receptors on activated human B cells

http://www.wikidata.org/entity/Q36349561

description

1984 nî lūn-bûn

@nan

1984年の論文

@ja

1984年学术文章

@wuu

1984年学术文章

@zh-cn

1984年学术文章

@zh-hans

1984年学术文章

@zh-my

1984年学术文章

@zh-sg

1984年學術文章

@yue

1984年學術文章

@zh

1984年學術文章

@zh-hant

name

Expression of interleukin 2 receptors on activated human B cells

@ast

Expression of interleukin 2 receptors on activated human B cells

@en

type

label

Expression of interleukin 2 receptors on activated human B cells

@ast

Expression of interleukin 2 receptors on activated human B cells

@en

prefLabel

Expression of interleukin 2 receptors on activated human B cells

@ast

Expression of interleukin 2 receptors on activated human B cells

@en

P1433

Q36349561-37576681-C135-4F0A-9620-FEFF64E19A5F

P1476

Q36349561-4995E6C0-F920-4415-A77B-A61A1BB35782

P2093

Q36349561-2854B6A7-DC0A-40C4-9890-5D8809C6FCC3

Q36349561-3A99AB22-345A-4C51-A5C3-F76765D5714D

Q36349561-67F3D60F-5B1C-4C0B-B32B-F5A3F8AA5487

Q36349561-7DE15096-A152-4EAF-BC34-A06DF732A653

Q36349561-7F34CCC0-5845-460D-B36D-78ACB909523A

Q36349561-8746C3FB-A3B2-4871-B6A8-2D1A1D26FAC4

Q36349561-88BFB3D4-444D-4EF9-B0D8-32D3BD900BA5

Q36349561-8BCEC704-44F8-4A72-B6B0-F175736DC50B

Q36349561-FB77ADE6-DF22-4C85-9581-30E90B6C53F7

P2860

Q36349561-22018A00-3823-4CA9-BC2A-C02092AF774A

Q36349561-2FAD8E7D-D8BA-47CC-AD1A-76A9A0A09781

Q36349561-3169603A-83B6-43D7-8132-235E89E2656C

Q36349561-34B4A148-9B64-4373-BA4E-2ED400DF8776

Q36349561-3987F9E7-785D-45AA-99B8-C0C8717365F1

Q36349561-5CFC7FAB-ABB9-4637-BDE6-0016E099ED8D

Q36349561-65727145-5DBE-4ACA-B03E-292AFE5BCA15

Q36349561-66BB9A6D-40FA-4975-9014-CBBE572B6B52

Q36349561-68DC83B8-FF91-4AA8-BE32-068F71492FDF

Q36349561-6E69C4F4-F5AD-4723-BC08-B9346C7AE5D0

P304

Q36349561-08D0A4B8-E552-428C-AAAD-8F94CEEB34E4

P31

Q36349561-5C2B3B8E-CB75-4CAD-8607-1C347F8E5300

P356

Q36349561-46D74DE0-4BBF-49C6-966F-B3D59D325D1F

P407

Q36349561-F6E11A3A-66FA-453C-97F8-C1438F9D4610

P433

Q36349561-965A3F66-7D75-4234-ABF1-050EFCECA3B1

P478

Q36349561-2E18D828-19A3-4FE1-B208-32E0D138295F

P577

Q36349561-63824EA8-D64F-4426-B1D5-FCF79ADBD894

P5875

Q36349561-EA9B0FEA-620C-46F2-9EBD-B94999C8F438

P698

Q36349561-4E928767-614A-4F8F-9FDE-F0B88C5C062D

P932

Q36349561-4442B2A4-A50B-4D21-AB69-53C5D9B77953

P356

P1433

Journal of Experimental Medicine

P1476

Expression of interleukin 2 receptors on activated human B cells

@en

P2093

Bongiovanni KF

http://www.w3.org/2001/XMLSchema#string

Depper JM

http://www.w3.org/2001/XMLSchema#string

Goldman CK

http://www.w3.org/2001/XMLSchema#string

Greene WC

http://www.w3.org/2001/XMLSchema#string

Korsmeyer SJ

http://www.w3.org/2001/XMLSchema#string

Leonard WJ

http://www.w3.org/2001/XMLSchema#string

Robb RJ

http://www.w3.org/2001/XMLSchema#string

Sharrow SO

http://www.w3.org/2001/XMLSchema#string

Waldmann TA

http://www.w3.org/2001/XMLSchema#string

P2860

Texas Red, a hydrophilic, red-emitting fluorophore for use with fluorescein in dual parameter flow microfluorometric and fluorescence microscopic studies

T cell-dependent activation of resting B cells: requirement for both nonspecific unrestricted and antigen-specific Ia-restricted soluble factors

The Sézary syndrome: a malignant proliferation of helper T cells.

Proliferation and differentiation of single hapten-specific B lymphocytes is promoted by T-cell factor(s) distinct from T-cell growth factor

T cell growth factor receptors. Quantitation, specificity, and biological relevance

B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor

T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells

Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor

Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I.

Serologic cross-reactivity between Class I MHC molecules and an H-2-linked differentiation antigen as detected by monoclonal antibodies

P304

1450-1466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.160.5.1450

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P577

1984-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270785616

http://www.w3.org/2001/XMLSchema#string

P698

6092511

http://www.w3.org/2001/XMLSchema#string

P932

2187491

http://www.w3.org/2001/XMLSchema#string